Shanghai Junshi Biosciences Co Ltd
SSE:688180
Operating Margin
Shanghai Junshi Biosciences Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CN |
Market Cap | 22.8B CNY |
Operating Margin |
-165%
|
Country | US |
Market Cap | 291B USD |
Operating Margin |
29%
|
Country | US |
Market Cap | 167.8B USD |
Operating Margin |
24%
|
Country | US |
Market Cap | 115.5B USD |
Operating Margin |
41%
|
Country | US |
Market Cap | 108.7B USD |
Operating Margin |
30%
|
Country | AU |
Market Cap | 134.3B AUD |
Operating Margin |
26%
|
Country | US |
Market Cap | 84.7B USD |
Operating Margin |
32%
|
Country | US |
Market Cap | 54B USD |
Operating Margin |
-100%
|
Country | US |
Market Cap | 43.1B USD |
Operating Margin |
-33%
|
Country | US |
Market Cap | 33.7B USD |
Operating Margin |
22%
|
Country | KR |
Market Cap | 38.7T KRW |
Operating Margin |
30%
|
Profitability Report
View the profitability report to see the full profitability analysis for Shanghai Junshi Biosciences Co Ltd.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Shanghai Junshi Biosciences Co Ltd's most recent financial statements, the company has Operating Margin of -165%.